Snyder Wins Multi-Drug Contract From Forest Labs

Business Wire, Sept 14, 1998

BETHESDA, Md.--(BUSINESS WIRE)--September 14, 1998--Snyder Communications, Inc. (NYSE: SNC) announced today that it won a new multi-drug pharmaceutical sales contract from Forest Laboratories Inc. (AMEX: FRX). This represents a new client win for Snyder Communications' Healthcare Sales unit.

Under the agreement with Forest, Snyder Healthcare Sales will provide national sales detailing and field management for multiple Forest drugs, including Aerobid, an inhaled steroid for the treatment of asthma; Tiazac, a cardiovascular drug; and Monurol, an antibiotic. More than 200 technically trained sales representatives will be dedicated to this effort.

Daniel M. Snyder, Chairman and Chief Executive Officer of Snyder Communications, commented, "We are excited to be working with Forest Laboratories and welcome them to Snyder Healthcare Sales' client base of the world's leading pharmaceutical manufacturers. As with all of our blue chip clients, our established national recruitment network and industry leading sales training services will ensure that Forest receives the highest possible return on investment for this critical program."

Snyder Healthcare Sales, Inc., a wholly owned subsidiary of Snyder Communications, is the world's leading provider of outsourced pharmaceutical sales and marketing solutions and sales force recruitment services. Snyder Healthcare Sales functions as a total service provider, going beyond traditional contract sales organizations by utilizing other value-added offerings from Snyder Communications' global network, including strategic analysis, consulting services, educational programs, direct-to-consumer advertising and sampling services. Snyder Healthcare Sales has longstanding relationships with many of the world's leading pharmaceutical manufacturers, including Bristol Myers Squibb, Eli Lilly & Co., Abbott Laboratories, Novartis Consumer Health, Boehringer Ingelheim Pharmaceuticals and Zeneca Pharmaceuticals, and employs more than 4,000 technically trained sales representatives and managers in offices throughout the world.

Snyder Communications, Inc. is a leading provider of fully integrated outsourced marketing solutions primarily for Fortune 500 size companies. Snyder identifies high-value market segments; designs and implements marketing programs to reach them; initiates and closes sales on behalf of its clients; and provides customer care, retention and loyalty marketing services. Snyder's resources include proprietary databases of targeted consumers and small businesses; database management services; pharmaceutical detailing services; pharmaceutical consulting; medical educational communications; proprietary product sampling programs and publications; sponsored information displays in proprietary locations; marketing program consultants; creative services; field sales and marketing representatives; customer service representatives; and direct mail and fulfillment capabilities. Snyder has offices throughout the United States, the United Kingdom, France, Ireland and Hungary.

   CONTACT:  Snyder Communications, Inc.
              Clay Perfall
              Chief Financial Officer
              (301) 571-6270
                 or
              Dewe Rogerson Inc.
              David Pasquale (Investors)
              Fielding Dupuy (Media)
              (212) 688-6840